World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
18478
World Ranking
1929
National Ranking
72

Pierre Tiberghien publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pierre Tiberghien sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 377 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pierre Tiberghien D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pierre Tiberghien sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Pierre Tiberghien is affiliated with the University of Franche-Comté in France and has contributed extensively to the field of medicine, with a particular focus on infectious diseases and hematology. Their research publications predominantly address topics related to blood donation and transfusion practices, COVID-19 clinical research, and the management of blood transfusions.

The scientist's recent publications include the following:

  • "Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19," 2020, published in Blood
  • "Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?", 2020, Vox Sanguinis
  • "Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019," 2020, Clinical Infectious Diseases
  • "No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation," 2020, Blood
  • "Potential human transmission of amyloid β pathology: surveillance and risks," 2020, The Lancet Neurology

Their research covers several main fields and subfields of study including:

  • Medicine
  • Infectious Diseases
  • Management of Technology and Innovation
  • Hematology
  • Biochemistry
  • Genetics

Main topics in their body of work include:

  • Blood donation and transfusion practices
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Blood transfusion and management
  • Blood groups and transfusion
  • Long-Term Effects of COVID-19
  • Hemoglobinopathies and Related Disorders

Pierre Tiberghien frequently collaborates with several other researchers, including:

  • Pascal Morel (36 joint publications)
  • Pascale Richard (29 joint publications)
  • Pierre Gallian (19 joint publications)
  • Karine Lacombe (17 joint publications)
  • Syria Laperche (16 joint publications)

The scientist's work has been published in various reputable journals, with the most frequent publication venues being:

  • Vox Sanguinis (39 publications)
  • Transfusion Clinique et Biologique (28 publications)
  • Transfusion (10 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (4 publications)
  • Blood (3 publications)

Best Publications

  • Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells

    Zohair Selmani;Abderrahim Naji;Ines Zidi;Benoit Favier

  • Age of Transfused Blood in Critically Ill Adults

    Jacques Lacroix;Paul C. Hébert;Dean A. Fergusson;Alan Tinmouth

  • Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference

    Markus M. Mueller;Hans Van Remoortel;Patrick Meybohm;Kari Aranko

  • Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea.

    J van Griensven;T Edwards;X de Lamballerie;MG Semple

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Administration of herpes simplex–thymidine kinase–expressing donor T cells with a T-cell–depleted allogeneic marrow graft

    Pierre Tiberghien;Christophe Ferrand;Bruno Lioure;Noël Milpied

  • All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases.

    P Fenaux;S Castaigne;H Dombret;E Archimbaud

  • Ganciclovir Treatment of Herpes Simplex Thymidine Kinase-Transduced Primary T Lymphocytes: An Approach for Specific In Vivo Donor T-cell Depletion After Bone Marrow Transplantation?

    P Tiberghien;CW Reynolds;J Keller;S Spence

  • Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19.

    Thomas Hueso;Thomas Hueso;Cécile Pouderoux;Hélène Péré;Anne Lise Beaumont

  • The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Unknown

  • Risk Factors for Acute Graft-Versus-Host Disease After Human Leukocyte Antigen–Identical Sibling Transplants for Adults With Leukemia

    Theresa Hahn;Philip L. McCarthy;Mei Jie Zhang;Dan Wang

  • A nationwide survey of hepatitis E viral infection in French blood donors.

    Jean Michel Mansuy;Pierre Gallian;Chloé Dimeglio;Karine Saune

  • Use of amniotic membrane transplantation in the treatment of venous leg ulcers

    Isabelle Mermet;Nathalie Pottier;Jean Marie Sainthillier;Carole Malugani

  • Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease.

    P Herve;M Flesch;P Tiberghien;J Wijdenes

  • Relevance of Toll-like receptor-4 polymorphisms in renal transplantation.

    Didier Ducloux;Marina Deschamps;Maria Yannaraki;Christophe Ferrand

  • Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease

    Daisy Bougard;Jean-Philippe Brandel;Maxime Bélondrade;Vincent Béringue

  • Role of STAT3 in CD4+CD25+FOXP3+ Regulatory Lymphocyte Generation: Implications in Graft-versus-Host Disease and Antitumor Immunity

    Jean-René Pallandre;Emilie Brillard;Gilles Créhange;Amandine Radlovic

  • HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells.

    Zohair Selmani;Abderrahim Naji;Emilie Gaiffe;Laurent Obert

  • Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.

    Hakumei Oh;Fausto R. Loberiza;Mei Jie Zhang;Olle Ringdén

  • Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion.

    F Kleinclauss;S Perruche;E Masson;M de Carvalho Bittencourt

  • Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers

    Marcelo de Carvalho Bittencourt;Sylvain Perruche;Emmanuel Contassot;Stéphanie Fresnay

Frequent Co-Authors

Christophe Borg
Christophe Borg Centre Hospitalier Universitaire de Besançon
Dana V. Devine
Dana V. Devine University of British Columbia
Jacques Izopet
Jacques Izopet Federal University of Toulouse Midi-Pyrénées
Mauricette Michallet
Mauricette Michallet University of Helsinki
Olle Ringdén
Olle Ringdén Karolinska Institute
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
Pierre Bordigoni
Pierre Bordigoni Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can broaden career prospects. Many students consider advanced nursing roles such as Nurse Practitioners, which blend clinical expertise with patient care. Finding programs that fit one’s lifestyle is key, and exploring the easiest np program options can help streamline the path to certification.

Specializing further, Psychiatric Mental Health Nurse Practitioner (PMHNP) programs offer opportunities to focus on mental health within immunological and neurological conditions. Those interested might want to research pmhnp programs online with best clinical placement to ensure hands-on experience in real-world settings, an essential factor for success in healthcare careers.

Cost efficiency is also critical. Students should consider the cheapest pmhnp programs online to access quality education without overwhelming debt. This approach allows greater focus on learning and career development.

Finally, understanding potential earnings is vital when planning long-term career goals. Nursing professionals with a Doctor of Nursing Practice (DNP) degree often enjoy competitive salaries, which can vary by location. Check the latest data on how much do dnp nurses make to make informed decisions about where to live and work.

Best Scientists Citing Pierre Tiberghien

Trending Scientists

Recently Published Articles